Doctors with the American Thoracic Society will discuss new research about the potential effect of estrogen on hypertension for women in menopause, and the link between hormone replacement and breast cancer risk. How can patients and doctors weigh the risks and benefits and decide whether or not estrogen is right for them?
Pediatric Impact of COVID-19 and Other Respiratory Infections Clinical Prediction Tool for Prioritizing Respiratory Syncytial Virus Prevention Products for High-Risk Infants During Current Limited Availability of Nirsevimab in the United States
A National Institutes of Health five-year, $2.8 million grant to Wits and Vanderbilt University will advance traditional health practitioner-initiated HIV testing.
Center hosts inaugural conference joined by leaders from across public and private sectors
The World Health Organization’s governing body is scheduled to meet on May 27 to discuss a critically needed plan for global pandemic preparedness.
What’s the best way to communicate with a vaccine-hesitant person about a vaccine’s potential benefits? New research from Binghamton University, State University of New York found that a one-size-fits-all approach to communicating messages isn’t effective.
A study by researchers at Washington University School of Medicine in St. Louis has found that repeat vaccination with updated versions of the COVID-19 vaccine promotes the development of antibodies that neutralize a wide range of variants of the virus that causes COVID-19, as well as related coronaviruses.
Vaccines remain the gold standard of protection against dangerous pathogens, but take considerable time and vast resources to develop. Rapidly mutating viruses such as SARS-CoV-2 can blunt their effectiveness and even render them obsolete.
Researchers have developed a groundbreaking electrostatic air sampler that enhances the rapid monitoring of airborne influenza and coronavirus. The device, capable of high air flow rates, offers significant advancements in detecting viral presence in indoor environments through polymerase chain reaction (PCR) analysis.
Leptospirosis is an illness caused by a bacteria called leptospira that can be present in soil and stagnant water. Rodents and other wildlife carry the bacteria and spread it through their urine. Both humans and dogs can become sick with leptospirosis, while cats are considered disease-resistant. For both people and dogs, the result of infection can range from mild to deadly serious.
Changing people’s behavior until a vaccine could be developed prevented roughly 800,000 COVID-19 deaths in the U.S., according to new CU Boulder and UCLA research. But the authors stress that interventions like lockdowns and school closures came at great economic and social cost.
Researchers at Fred Hutch Cancer Center have found in pre-clinical studies that an experimental gene therapy for genital and oral herpes removed 90% or more of the infection and suppressed how much virus can be released from an infected individual, which suggests that the therapy would also reduce the spread of the virus.
Researchers from the Biological Threat Response Laboratory played a critical role in testing for the virus.
Member States of the World Health Organization (WHO) were due to converge on text for a global pandemic agreement during their ninth and final negotiating session in March; however, insufficient progress was made in those two weeks, in terms of finding consensus.
Over 150 researchers from across the University of Utah gathered to form new connections and share groundbreaking research on topics from antibiotic resistance to autoimmune diseases.
A group of UC San Diego researchers, centered at UC San Diego's Institute for Network Medicine, teamed up with rheumatologists at the University of Leeds in the United Kingdom to solve a medical mystery.
Shruti Mehta, PhD, MPH, has been named The Dr. Charles Armstrong Chair in Epidemiology and Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, effective June 1.
Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains that closely mirror the one recently detected in cows, chickens and one person in Texas.
Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infection typically presents with fever and respiratory symptoms, which can progress to
For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study found.
A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April), according to Vanderbilt University Medical Center (VUMC) research published in Open Forum Infectious Diseases and to be presented at the American Thoracic Society 2024 International Conference.
A nationwide survey of people who were pregnant or trying to become pregnant found that overall 54 percent expressed interest in the RSV vaccine during pregnancy. Perceiving RSV as a serious illness in infants was the strongest predictor of likely vaccination during pregnancy. Likelihood to receive the RSV vaccine during pregnancy was also higher among parents with a child at home already. Findings were published in the journal Pediatrics.
The Sabin Vaccine Institute presented the Albert B. Sabin Gold Medal to physician-researchers Keith Klugman and Shabir Madhi.
America is going the wrong way when it comes to prescribing antibiotics, with 1 in 4 prescriptions going to patients who have conditions that the drugs won’t touch, a new study finds.
New research has given insight into the resilience and recovery of businesses in two South Australian regions following a major bushfire event and disruptions caused by the COVID-19 pandemic.
New study details long-sought mechanisms and structures
Although the current avian influenza outbreak began more than two years ago, detections have been made in recent weeks in cattle, cats and large commercial poultry flocks across the country and in Michigan.
HealthTrackRx, the nation's premier molecular diagnostic testing laboratory, today announced the appointment of Steven Goldberg, MD, MBA, as its Chief Medical Officer (CMO).
The humanized monoclonal antibody known as hu1F5, which specifically binds to the fusion (F) glycoprotein of both Nipah virus and Hendra virus and prevents virus infection of cells (neutralizes) has now proven effective in protecting against the often fatal Nipah virus in animal studies.
To better understand COVID-19’s spread during the pandemic, public health officials expanded wastewater surveillance. These efforts track SARS-CoV-2 levels and health risks among most people, but they miss people who live without shelter, a population particularly vulnerable to severe infection.
Researchers at UC San Diego have received new grants that will help develop full-body imaging techniques to detect inflammation, which is currently very difficult to visualize in the clinic.
Valley fever is a fungal respiratory infection that’s stealthily spreading through the soil and dust throughout the American West. An interdisciplinary research team is trying to map where the disease-causing fungus can survive and where it’ll spread as the climate changes.
Researchers at the Georgia Institute of Technology and the University of Wisconsin-Madison have developed a new vaccine that offers broad protection against not only SARS-CoV-2 variants, but also other bat sarbecoviruses.
A study from the University of Notre Dame, Massachusetts General Hospital and the National Institutes of Health has identified a combination of medications that may improve blood flow within granulomas, benefiting drug delivery.
A team of scientists led by Prof Guillermo Bazan from NUS Institute for Functional Intelligent Materials (I-FIM) has developed a novel antibiotic named COE-PNH2 that is capable of combating hard-to-treat mycobacterial lung infections.
A vaccine against the bacterium that causes melioidosis was highly protective against the disease, which is endemic in many tropical areas, causing approximately 165,000 cases with 89,000 fatalities around the world each year. It is so dangerous that it is categorized as a Tier 1 Select Agent of bioterrorism.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
